Radiofrequency Ablation of Metastases from Osteosarcoma in Patients Under 25 Years: The SCFE Experience

REFERENCES

• Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006;30(1):177–183.
   Google Scholar
• de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587–596.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–628.
   PubMed Web of Science ®Google Scholar
• Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer. 2007;109(7):1397–1405.
   Google Scholar
• Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243(1):268–275.
   PubMed Web of Science ®Google Scholar
• Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation–an international study survey. Anticancer Res. 2004;24(1):339–343.
   PubMed Web of Science ®Google Scholar
• Motamedi D, Learch TJ, Ishimitsu DN, et al. Thermal ablation of osteoid osteoma: overview and step-by-step guide. Radiographics. 2009;29(7):2127–2141.
   Google Scholar
• Rosenthal DI, Hornicek FJ, Torriani M, et al. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171–175.
   PubMed Web of Science ®Google Scholar
• Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002:224(1):87–97.
   Google Scholar
• Clarencon F, Jean B, Pham HP, et al. Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases. Skeletal Radiol. 2011;42(1):25–36.
   Google Scholar
• Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116(4):989–997.
   PubMed Web of Science ®Google Scholar
• Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22(2): 300–306.
   PubMed Web of Science ®Google Scholar
• Thanos L, Mylona S, Galani P, et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 2008;37(3):189–194.
   PubMed Web of Science ®Google Scholar
• van Laarhoven S, van Baren R, Tamminga RY, de Jong KP. Radiofrequency ablation in the treatment of liver tumors in children. J Pediatr Surg. 2012;47(3):e7–e12.
   Web of Science ®Google Scholar
• Sugito K, Kusafuka T, Hoshino M, et al. Application of radiofrequency ablation for giant solid pseudopapillary tumor of the pancreas. Pediatr Int. 2010;52(1):e29–e31.
   Google Scholar
• Ilaslan H, Schils J, Joyce M, et al. Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol. 2010;39(2):169–173.
   PubMed Web of Science ®Google Scholar
• Hoffer FA, Daw NC, Xiong X, et al. A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors. Cancer. 2009;115(6):1328–1337.
   Google Scholar
• Bielack SS, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol. 2009;27(4): 557–565.
   PubMed Web of Science ®Google Scholar
• Harting MT, Blakely ML, Jaffe N, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg. 2006;41(1):194–199.
   PubMed Web of Science ®Google Scholar
• Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer. 2005;104(8):1721–1725.
   PubMed Web of Science ®Google Scholar
• Letourneau PA, Xiao L, Harting MT, et al. Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome. J Pediatr Surg. 2011;46(7):1333–1337.
   Google Scholar
• Meyer WH, Schell MJ, Kumar AP, et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer. 1987;59(2):374–379.
   PubMedGoogle Scholar
• Diemel KD, Klippe HJ, and Branseheid D. Pulmonary metastasetomy for osteosarcoma: is it justified? Recent Results Cancer Res. 2009;179:183–208.
   Google Scholar
• Karplus G, McCarville MB, Smeltzer MP, et al. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases? J Pediatr Surg. 2009;44(4):665–671.
   Google Scholar
• Okuma T, Matsuoka T, Yamamoto A, et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol. 2010;33(4):787–793.
   PubMed Web of Science ®Google Scholar
• Kashima M, Yamakado K, Takaki H, et al., Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol. 2011;197(4):W576–W580.
   PubMed Web of Science ®Google Scholar
• Palussiere J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol. 2011;34(5):989–997.
   PubMed Web of Science ®Google Scholar
• Rybak LD, Rosenthal D, Wittig JC. Chondroblastoma: radiofrequency ablation–alternative to surgical resection in selected cases. Radiology. 2009;251(2):599–604.
   Google Scholar
• Albisinni U, Rimondi E, Malaguti MC, Ciminari R. Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol. 2004;183(1):245; author reply 245–246.
   Google Scholar
• Neeman Z, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol. 2002;179(5):1330–1332.
   Google Scholar
• Rosenthal D, Callstrom MR. Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology. 2012;262(3):765–780.
   PubMed Web of Science ®Google Scholar
• Le Deley MC, Guinebretiere JM, Gentet JC, et al., Societe Francaise d'Oncologie Pediatrique (SFOP). SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer. 2007;43(4):752–761.
   PubMed Web of Science ®Google Scholar
• Sarcome 09/0603: EudraCT # 2006–00337727 promoted by UNICANCER
   Google Scholar